CooperSurgical to acquire the Cook Medical’s Reproductive Health division

Cook Medical’s Reproductive Health sector produced annual revenues of $158 million in 2021, a year-over-year increase of 17%. The acquisition will allow for the expansion and leverage of CooperSurgical’s fertility, labor & delivery offerings across Asia-Pacific countries, where the company estimates approximately 50% of new fertility clinic builds in 2022 will take place. Cook’s well-established devices will strengthen Cooper’s growing portfolio and include fertility products such as needles, pipettes, catheters, and equipment. Cooper’s obstetric and gynecological products include devices for vacuum-assisted delivery, fetal monitoring, infant critical care, and cord blood and tissue storage.

The decision also allows Cooper to potentially leverage Costa Rica manufacturing facilities, reduce cost, increase efficiencies, and add more than 100 individuals to the company’s sales force internationally.

Reference

1. Press release. CooperCompanies to Acquire Cook® Medical’s Reproductive Health Business. Accessed February 10, 2022. https://investor.coopercos.com/static-files/02c9e306-3f90-4926-82ca-09340f3f6323